Cardiovascular Risk—What Should Be Measured?
- 31 May 1986
- journal article
- editorial
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 61 (5) , 396-398
- https://doi.org/10.1016/s0025-6196(12)61961-2
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Apolipoprotein A-I as a Marker of Angiographically Assessed Coronary-Artery DiseaseNew England Journal of Medicine, 1983
- Some considerations of methodology and standardization of apolipoprotein B immunoassays.Clinical Chemistry, 1983
- Multivariate analyses of serum apolipoproteins and risk factors in relation to acute myocardial infarction.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1981
- Quantitative determination of human plasma apolipoprotein A-I by laser immunonephelometry.Clinical Chemistry, 1981
- Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins].Proceedings of the National Academy of Sciences, 1980
- Quantitation of apolipoprotein A-I of human plasma high density lipoproteinMetabolism, 1976
- Lp(a) lipoprotein and pre‐β1‐lipoprotein in patients with coronary heart diseaseClinical Genetics, 1974
- The Structure of Human High Density Lipoprotein and the Levels of Apolipoprotein A-I in Plasma as Determined by RadioimmunoassayJournal of Clinical Investigation, 1974
- Apoliproproteins and lipoproteinsAtherosclerosis, 1971
- Über die Wirkung des tierischen Eiweißes auf die Aorta und die parenchymatösen Organe der KaninchenVirchows Archiv, 1909